Company: LCTX
Filing Date: 2025-03-10
Form Type: 10-K
Source: 0000950170-25-036309
Chunk: 161

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-03-10
Form: 10-K
Item: Item 1B
Chunk 161
---
88

    Common shares received and retired for employee taxes paid

    (23
    )

    (37
    )

    Proceeds from sale of common shares under ATM, net of offering costs

    68

    6,426

    Proceeds from sale of common shares under registered direct financing, net of offering costs

    13,889

    —

    Proceeds from sale of common shares with warrants under registered direct financing, net of offering costs

    21,919

    —

    Payment of financed insurance premium

    (171
    )

    —

    Repayment of finance lease liabilities

    (54
    )

    (54
    )

    Net cash provided by financing activities

    35,857

    6,423

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

    (95
    )

    (250
    )

    NET INCREASE IN CASH, CASH EQUIVALENTS AND    RESTRICTED CASH

    10,362

    24,056

    CASH, CASH EQUIVALENTS AND RESTRICTED CASH:

    At beginning of the period

    35,992

    11,936

    At end of the period
     
    $
    46,354

    $
    35,992

    SUPPLEMENTAL DISCLOSURES:

    Cash paid for interest
     
    $
    9

    $
    10

    SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING AND    INVESTING ACTIVITIES:

    Financing costs in accounts payable and accrued liabilities
     
    $
    179

    $
    —

    Fair value of warrant liability recognized upon issuance in registered direct financing
     
    $
    8,289

    $
    —

    Financed insurance premium
     
    $
    855

    $
    —

    Reconciliation of cash, cash equivalents and restricted cash, end of period:

    Cash and cash equivalents
     
    $
    45,789

    $
    35,442

    Restricted cash included in deposits and other long-term assets    (see Note 13 (Commitments and Contingencies))

    565

    550

    Total cash, cash equivalents, and restricted cash
     
    $
    46,354

    $
    35,992

See